Biosyngen Received The Asia Pacific Cell & Gene Therapy Excellence Awards (apcgtea) 2023

By Author: Orson Amiri
Total Articles: 401
Comment this article

Prof. Thiery's Vision for Cell and Gene Therapy: During his acceptance speech, Professor Jean Paul Thiery articulated his vision for the future of cell and gene therapy. He not only expressed gratitude for the committee's recognition but also underscored the transformative potential of these therapies. Prof. Thiery highlighted their capacity to drive groundbreaking advancements and unlock limitless opportunities within the biotechnology industry. Moreover, he emphasized the critical importance of fostering open communication and collaboration among all stakeholders to address industry challenges and expedite the development of gene and cell therapy medications. Looking ahead, he anticipates more successful clinical trials and the approval of even more innovative cell and gene therapies that will ultimately benefit a larger population of patients.

Read More - https://www.techdogs.com/tech-news/pr-newswire/biosyngen-received-the-asia-pacific-cell-gene-therapy-excellence-awards-apcgtea-2023